Protein phosphatase 2A Cα is involved in osteoclastogenesis by regulating RANKL and OPG expression in osteoblasts

Bench to bedside: elucidation of the OPG–RANK–RANKL pathway and the development of denosumab

(2012) David L. Lacey et al.   NATURE REVIEWS DRUG DISCOVERY

Intercellular Cross-Talk Among Bone Cells: New Factors and Pathways

(2012) Natalie A. Sims et al.   Current Osteoporosis Reports

Reduction of protein phosphatase 2A Cα enhances bone formation and osteoblast differentiation through the expression of bone-specific transcription factor Osterix

(2011) Hirohiko Okamura et al.   BONE

MHC class II transactivator negatively regulates RANKL-mediated osteoclast differentiation by downregulating NFATc1 and OSCAR

(2010) Jung Ha Kim et al.   CELLULAR SIGNALLING

NFATc1: Functions in osteoclasts

(2009) Qingxiao Zhao et al.   INTERNATIONAL JOURNAL OF BIOCHEMISTRY & CELL BIOLOGY

Upstream Stimulatory Factors Regulate OSCAR Gene Expression in RANKL-Mediated Osteoclast Differentiation

(2008) Jung Ha Kim et al.   JOURNAL OF MOLECULAR BIOLOGY